The causes of a peripheral blood eosinophilia in a secondary care setting
- PMID: 34080735
- DOI: 10.1111/cea.13889
The causes of a peripheral blood eosinophilia in a secondary care setting
Abstract
Background: A peripheral blood eosinophilia of greater than 1.0 × 109 /L is relatively unusual and offers a clue to the underlying diagnosis. In 2003, we established a specialist service to diagnose unexplained eosinophilia.
Objective: To describe the causes of an eosinophilia in our service and the diagnostic algorithm we developed.
Methods: Subjects were referred by physician colleagues across a range of specialties and undertook standard investigations following a semi-structured protocol. Data were extracted from a bespoke database.
Results: Three hundred and eighty two subjects were referred over a 17-year period. Average age was 54 years and 183 (48%) of subjects were female, with 21 of 25 (84%) females in the idiopathic eosinophilic pneumonia group (p < 0001), 22 of 30 (73%) females in the gastrointestinal disease group (p < .008), but 11 of 37 (30%) females in the eosinophilic granulomatosis with polyangiitis group (p < .04). A diagnosis was assigned after systematic evaluation using a pre-defined algorithm in 361 (94.5%) of cases. Fungal allergy (82 subjects: 21%), parasitic infection (61 subjects: 16%) and severe eosinophilic asthma (50 subjects: 13%) were the three commonest individual diagnoses. Hypereosinophilic syndrome (HES) disease including eosinophilic granulomatosis with polyangiitis (EGPA) accounted for 85 subjects (20%) of which seven subjects (2%) had myeloproliferative disease (M-HES). A high IgE was common, and 79 (91%) of subjects with complete data who had an IgE of ≥1000 IU/L had fungal allergy or parasite infection. The serum tryptase was raised in 44 of 302 (14.5%) of individuals across all diagnostic groups, though none had mastocytosis.
Conclusion: A diagnosis of an unexplained eosinophilia can usually be determined using as semi-structured algorithm. Parasitic infection and fungal allergy often with severe eosinophilic asthma were common causes, whereas HES, particularly myeloproliferative, disease was relatively rare.
Keywords: EGPA; IgE; eosinophils; fungal; hypereosinophilic syndrome; parasites.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Causes of hypereosinophilia in 100 consecutive patients.Eur J Haematol. 2020 Sep;105(3):292-301. doi: 10.1111/ejh.13437. Epub 2020 May 18. Eur J Haematol. 2020. PMID: 32364630
-
Marked and persistent eosinophilia in the absence of clinical manifestations.J Allergy Clin Immunol. 2014 Apr;133(4):1195-202. doi: 10.1016/j.jaci.2013.06.037. Epub 2013 Aug 26. J Allergy Clin Immunol. 2014. PMID: 23987798 Free PMC article.
-
A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia.Mil Med Res. 2017 May 23;4:15. doi: 10.1186/s40779-017-0124-7. eCollection 2017. Mil Med Res. 2017. PMID: 28546866 Free PMC article.
-
[Differential diagnosis of hypereosinophilia].Z Rheumatol. 2019 May;78(4):313-321. doi: 10.1007/s00393-018-0587-2. Z Rheumatol. 2019. PMID: 30635705 Review. German.
-
A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.BMC Pulm Med. 2018 Nov 29;18(1):181. doi: 10.1186/s12890-018-0733-2. BMC Pulm Med. 2018. PMID: 30497438 Free PMC article. Review.
Cited by
-
Characteristics of patients with incidental eosinophilia admitted to a tertiary hospital in southern China.Heliyon. 2023 Apr 20;9(5):e15569. doi: 10.1016/j.heliyon.2023.e15569. eCollection 2023 May. Heliyon. 2023. PMID: 37144198 Free PMC article.
-
New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease.J Asthma Allergy. 2021 May 25;14:557-573. doi: 10.2147/JAA.S251709. eCollection 2021. J Asthma Allergy. 2021. PMID: 34079294 Free PMC article. Review.
-
Prevalence and management of eosinophilia based on periodic health examinations in primary care clinics.Asian Biomed (Res Rev News). 2023 Jun 16;16(5):273-282. doi: 10.2478/abm-2022-0030. eCollection 2022 Oct. Asian Biomed (Res Rev News). 2023. PMID: 37551315 Free PMC article.
-
Optimizing diagnostic and management pathways for patients with eosinophilia of unknown origin: a multidisciplinary protocol for urgent and non-urgent evaluation.Front Med (Lausanne). 2025 Jun 4;12:1544047. doi: 10.3389/fmed.2025.1544047. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40534692 Free PMC article.
-
Unusual Presentation of an Uncommon Malignancy: A 74-Year-Old Woman with Aggressive Fibromatosis of the Large Intestine Presenting as a Liver Mass and the Therapeutic Management.Am J Case Rep. 2023 Oct 9;24:e939862. doi: 10.12659/AJCR.939862. Am J Case Rep. 2023. PMID: 37812585 Free PMC article.
References
REFERENCES
-
- Jacobsen EA, Jackson DJ, Heffler E, et al. Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies. Annu Rev Immunol. 2021;39(1):719-757.
-
- Klion AD, Ackerman SJ, Bochner BS. Contributions of eosinophils to human health and disease. Annu Rev Pathol. 2020;15:179-209.
-
- Yancey SW, Keene ON, Albers FC, et al. Biomarkers for severe eosinophilic asthma. J Allergy Clin Immunol. 2017;140(6):1509-1518.
-
- Hartl S, Breyer MK, Burghuber OC, et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020;55(5):1901874.
-
- Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147-174.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical